Clinical Trial

AI-Assisted Treatment for Residual Speech Sound Disorders

Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this randomized-controlled trial is to determine how artificial intelligence-assisted home practice may enhance speech learning of the "r" sound in school-age children with residual speech sound disorders. All child participants will receive 1 speech lesson per week, via telepractice, for 5 weeks with a human speech-language clinician. Some participants will receive 3 speech sessions per week with an Artificial Intelligence (AI)-clinician during the same 5 weeks as the human clinician sessions (CONCURRENT treatment order group), whereas others will receive 3 speech sessions per week with an AI-clinician after the human clinician sessions end (SEQUENTIAL treatment order group.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2023-08-04; most recent amendment 2026-01-07.
Status change: Not Yet Recruiting → Recruiting 2024-04-23
Trial Details
NCT Number NCT05988515
Lead Sponsor Syracuse University
Collaborators: National Institutes of Health (NIH), State University of New York - Upstate Medical University, National Institute on Deafness and Other Communication Disorders (NIDCD)
Conditions Speech Sound Disorder
Enrollment 26 participants
Start Date 2024-09-05
Primary Completion 2027-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-01-08